Decreased FEF50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study

Xuechen Wang,Fangyuan Li,Chengshuo Wang,Kai Huang,Shen Shen,Ming Wang,Jianmin Jin,Luo Zhang
DOI: https://doi.org/10.1097/cm9.0000000000002925
IF: 6.133
2024-02-06
Chinese Medical Journal
Abstract:To the Editor: While 20–60% of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have comorbid asthma (known as refractory asthma), asthma is undiagnosed in 25–48% of CRSwNP patients with comorbid asthma. [ 1 ] Moreover, the prevalence of persistent airflow limitation (PAL) is high in CRSwNP patients with comorbid asthma. However, the factors indicating comorbid asthma in patients with CRSwNP and reflecting PAL in those with comorbid asthma have not been fully elucidated. Small airway dysfunction (SAD) has been found in CRSwNP patients, even in the absence of asthma; and the severity of SAD in patients with comorbid asthma is correlated with the duration of asthma history. [ 2 ] This study therefore aimed to evaluate the clinical characteristics, especially small airway parameters as indicators of comorbid asthma in patients with CRSwNP and of PAL in CRSwNP patients with comorbid asthma. Besides, in order to identify the characteristics of CRSwNP patients with asthma, we also compared the prevalence of SAD and PAL between asthma patients with or without CRSwNP.
medicine, general & internal
What problem does this paper attempt to address?